U.S. FDA promotes the national priority voucher pilot program as a way to speed reviews, citing a 50 day full review for a novel chronic weight management drug and five approvals so far.
The American people deserve an FDA that is responsive and efficient.
Five drugs have been approved so far under the national priority voucher pilot program, which helps the agency move efficiently on applications that advance Americans’ key interests.
Today the FDA issued its fastest approval for a novel drug (NME) since 2002, as part of the national priority voucher pilot program.
Full FDA review completed in 50 days
5th national priority voucher approval
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new expert voices, debates, and emerging ideas.
← Back to Healthcare